With first-in-class technologies and experienced scientists, Creative Biolabs has successfully developed versatile glycoprotein production and analysis platforms. Based on these cutting-edge platforms, we can provide our worldwide clients with the largest and most diverse portfolio of standard or custom therapeutic glycoprotein production and analysis services.
We provide a full range of custom synthesis services, including glycans synthesis, glycopeptide synthesis and glycoprotein synthesis, with the highest quality and the most competitive price for global clients.
We have developed versatile glycoprotein production platforms to produce a variety of glycosylated biopharmaceuticals and optimize the glycosylation to improve activity and/or other properties like bioavailability, stability, and/or immunogenicity for better clinical performance.
We provide a series of technologies for glycoprotein analysis, including but not limited to lectin microarray, mass spectrometry (MS), liquid chromatography (LC) technology, high performance liquid chromatography (HPLC), to analyze glycoprotein structure, perform glycoprotein detection and test glycoprotein quantification.
We have successfully developed several efficient strategies including knockdown, overexpression and knockout/knockin by precision genome editing to provide a series of cell line glycoengineering services.
Several cutting-edge antibody discovery technologies, including phage display technology, hybridoma technology, and antigen-specific B lymphocytes sorting technology, are employed on our Anti-GlyTM platform for anti-glycoprotein antibody development.